Publication | Closed Access

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

Bone DiseaseHematological MalignancyBone HealthMedicineClinical TrialsBone Disease TreatmentMultiple MyelomaOsteoporosisOncologyRadiation OncologyOrthopaedic SurgeryPhase 3Health Sciences